CoChat

The Effect of the COVID-19 Pandemic on People with Parkinson’s Disease

Open access

Published version of a preprint

The DOI matches its Crossref record; 56 of the 57 references it cites were found in a registry or an index, and 1 are not checked yet.

Abstract

Background: The effect of the COVID-19 pandemic on people with Parkinson’s disease (PD) is poorly understood. Objective: To rapidly identify areas of need and improve care in people with PD during the COVID-19 pandemic, we deployed a survey to assess COVID-19 symptoms and the pandemic’s effect among those with and without COVID-19. Methods: People with and without PD participating in the online study Fox Insight (FI) were invited to complete a survey between April 23 and May 23, 2020. Among people reporting COVID-19 diagnoses, we compared symptoms and outcomes in people with and without PD. Among people not reporting COVID-19, we assessed access to healthcare and services and PD symptoms. Results: 7,209/9,762 active FI users responded (approximately 74% response rate), 5,429 people with PD and 1,452 without PD. COVID-19 diagnoses were reported by 51 people with and 26 without PD. Complications were more frequent in people with longer PD duration. People with PD and COVID-19 experienced new or worsening motor (63%) and nonmotor (75%) symptoms. People with PD not diagnosed with COVID-19 reported disrupted medical care (64%), exercise (21%), and social activities (57%), and worsened motor (43%) and non-motor (52%) symptoms. Disruptions were more common for those living alone, with lower income and non-White race. Conclusions: The COVID-19 pandemic is associated with wide-ranging effects on people with PD, and certain groups may be at particular risk. FI provides a rapid, patient-centered means to assess these effects and identify needs that can be used to improve the health of people with PD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3233/jpd-202249

Cites

56 of 57 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 CONSORT diagram depicting number of respondents included in the study.
Fig. 1 CONSORT diagram depicting number of respondents included in the study.CC BY · PubMed Central
Fig. 2 Distribution of survey responses and COVID-19 cases among respondents (A) within the US and (B) across the globe. The color of the state or country represents the number of survey responses and the size of the circles represents the number of COVID-19 diagnoses reported from each region.
Fig. 2 Distribution of survey responses and COVID-19 cases among respondents (A) within the US and (B) across the globe. The color of the state or country represents the number of survey responses and the size of the circles represents the number of COVID-19 diagnoses reported from each region.CC BY · PubMed Central
Fig. 3 Changes in (A) motor and (B - C) non-motor PD-related symptoms among respondents with PD and COVID-19 (n = 51).
Fig. 3 Changes in (A) motor and (B - C) non-motor PD-related symptoms among respondents with PD and COVID-19 (n = 51).CC BY · PubMed Central
Fig. 4 Changes in (A) motor and (B - C) non-motor PD-related symptoms among respondents with PD without COVID-19 (n = 5,378).
Fig. 4 Changes in (A) motor and (B - C) non-motor PD-related symptoms among respondents with PD without COVID-19 (n = 5,378).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 57 references

Research works printed but not linked: 3

  1. 10.1001/jama-neurol.2020.1452 · doi:10.1001/jama-neurol.2020.1452
  2. 10.1001/jmaneurol.2020.2581 · doi:10.1001/jmaneurol.2020.2581
  3. 10.1002/air.22680 · doi:10.1002/air.22680

Cited by

Metadata

Authors
Brown, E. G., Chahine, L. M., Goldman, S. M., Korell, M., Mann, E., Kinel, D. R., Arnedo, V., Marek, K. L., & Tanner, C. M.
Affiliations
  • University of California, San Francisco (US)
  • University of Pittsburgh (US)
  • University of Rochester (US)
  • Michael J. Fox Foundation (US)
  • Institute for Neurodegenerative Disorders (US)
Corresponding author
Tanner, Caroline M.
Venue
Journal of Parkinson's Disease
Published
2020-10-27
Volume
10
Issue
4
Pages
1365-1377
ISSN
  • 1877-7171 (ISSN-L)
  • 1877-718X
OpenAlex
W3086892979
Cited by
177
References
54
Citations by year
2026: 4 · 2025: 18 · 2024: 29 · 2023: 25 · 2022: 49 · 2021: 48 · 2020: 4
FWCI
13.64
Type
journal article
Language
en
Open access
Locations
  • Journal of Parkinson s Disease (publishedVersion, cc-by)
  • medRxiv (acceptedVersion)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • eScholarship (California Digital Library) (submittedVersion)
  • eScholarship (California Digital Library) (submittedVersion, cc-by)
Funders
  • U.S. Department of Defense
  • Michael J. Fox Foundation for Parkinson's Research
  • Biogen
  • University of Pittsburgh
  • Oscar Health
  • National Institutes of Health
  • Centers for Disease Control and Prevention
  • University of California, San Francisco
  • National Institute for Occupational Safety and Health
  • Agency for Toxic Substances and Disease Registry
Topics
  • Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
  • Health Sciences › Medicine › Oncology › COVID-19 and healthcare impacts
  • Social Sciences › Psychology › Clinical Psychology › COVID-19 and Mental Health
Keywords
Parkinson's disease, COVID-19 pandemic, COVID-19 symptoms, motor symptoms, non-motor symptoms, health care access, living alone, income inequality, racial disparities, disease duration
MeSH terms
COVID-19, Adult, Aged, Aged, 80 and over, Cross-Sectional Studies, Female, Health Services Accessibility, Humans, Male, Middle Aged, Parkinson Disease, Pneumonia, Viral, Surveys and Questionnaires, Coronavirus Infections, Young Adult, Pandemics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.